AOD-9604 in Catarman — Fat Loss Peptide Research Guide
AOD-9604 research guide for Catarman. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
Research-Grade AOD-9604 for Catarman Investigators
Most researchers searching for AOD-9604 in Catarman quickly find that local retail options are essentially nonexistent. This matters because AOD-9604 quality ranges widely across the market — from verified research-grade material to mislabeled or underdosed compounds — and the vendor determines everything about the product. Vendors worth sourcing from openly share batch-matched Certificates of Analysis containing HPLC chromatograms, mass spec identity confirmation, endotoxin levels, and residual solvent results — all for the exact batch you are purchasing. The sections below cover what Catarman researchers need to know about purchasing, testing, and working with AOD-9604 for legitimate research applications.
AOD-9604: What the Research Shows
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Catarman researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Where to Buy AOD-9604 — A Researcher's Guide
The first step for any Catarman researcher sourcing AOD-9604 is finding vendors with verified community track records — search results alone are too heavily influenced by marketing spend. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from gram-negative bacterial contamination can trigger severe inflammatory responses even at minute levels. Signs of a credible vendor beyond COA quality: established track record of at least two years, knowledgeable support capable of explaining COA data, and cold chain packaging that protects product integrity. Hold lyophilised AOD-9604 at freezer temperature (−20°C) until ready to use; reconstitute only the volume needed for upcoming use and store the rest at −20°C.
Order AOD-9604 — ships to Catarman
COA-verified · International tracking · Research grade
As a research compound, AOD-9604 has not been through the clinical trial process required for pharmaceutical approval — its safety profile is defined by animal study data and limited human studies. Proper handling of AOD-9604 requires strict sterile technique during reconstitution — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and consistent cold chain handling. Verify the endotoxin level in your AOD-9604 batch COA before any injectable research application — look for results stated as EU/mg and compare against acceptable research limits for your application. PubMed and bioRxiv provide the most complete literature coverage for AOD-9604 research; prioritise peer-reviewed studies with characterised source material over case reports or anecdotal evidence.
Frequently Asked Questions
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
